| |
| |
|
| Insider
Information: |
Wagner Charles F Jr |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Billerica |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
231,487 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,891,207 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
231,487 |
|
|
| Total
Value |
$32,891,207 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progress Software Corp |
PRGS |
EVP Finance & Admin an... |
2011-10-14 |
81,175 |
|
0 |
Premium* |
|
|
Bruker Corp |
BRKR |
EVP & Chief Financial ... |
2015-03-17 |
99,925 |
2012-08-02 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP & Chief Financial ... |
2024-05-28 |
50,387 |
2019-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-04-01 |
4 |
AS |
$261.42 |
$683,602 |
D/D |
(2,582) |
43,620 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-04-29 |
4 |
D |
$276.17 |
$151,065 |
D/D |
(547) |
43,073 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2022-05-02 |
4 |
AS |
$254.87 |
$88,778 |
D/D |
(343) |
42,730 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,026 |
72,890 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-10 |
4 |
D |
$294.33 |
$796,751 |
D/D |
(2,707) |
70,183 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$1,488,914 |
D/D |
(4,992) |
65,191 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-17 |
4 |
D |
$292.85 |
$1,098,188 |
D/D |
(3,750) |
61,441 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$956,409 |
D/D |
(3,308) |
58,133 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-10 |
4 |
AS |
$286.64 |
$604,709 |
D/D |
(2,088) |
56,045 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-13 |
4 |
AS |
$288.31 |
$783,346 |
D/D |
(2,666) |
53,379 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-17 |
4 |
AS |
$294.52 |
$592,786 |
D/D |
(2,000) |
51,379 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-03-24 |
4 |
AS |
$305.38 |
$539,912 |
D/D |
(1,768) |
49,611 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2023-11-20 |
4 |
AS |
$349.88 |
$1,049,640 |
D/D |
(3,000) |
46,693 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-01-02 |
4 |
AS |
$405.00 |
$1,215,000 |
D/D |
(3,000) |
43,693 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,254 |
58,947 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,114 |
66,061 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$1,102,083 |
D/D |
(2,607) |
63,454 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,590,038 |
D/D |
(3,750) |
59,704 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,182,671 |
D/D |
(2,812) |
56,892 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$1,428,793 |
D/D |
(3,309) |
53,583 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Financial Officer |
• – – |
2024-05-28 |
4 |
AS |
$454.79 |
$1,478,068 |
D/D |
(3,250) |
50,387 |
0 |
- |
|
46 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
